News about Global Pharma

ASPA Delivers Keynote at ASIA Security Conference and Exhibition

The Authentication Solution Providers’ Association (ASPA) has announced that Puneet Maithani, Associate Director of Industry Affairs has delivered a compelling keynote address titled ‘ASPA: Leading the Fight Against Counterfeiting and Ensuring Product Authenticity’ at the ASIA Security Conference & Exhibition.

Global Pharma | 05/08/2024 | By Aishwarya |  1085

Anivive Bags NIAID Contract Worth Up to USD 33 Million to Progress Valley Fever Vaccine

Anivive Lifesciences Inc. has announced that the National Institute of Allergy and Infectious Diseases (NIAID) has awarded Anivive a new contract worth up to USD 33 million to support the development of a vaccine against the fungus Coccidioides, which causes Valley Fever.

Global Pharma | 03/08/2024 | By Aishwarya |  867

Merck Acquires Mirus Bio to Advance Viral Vector Bioprocessing

Merck has completed the acquisition of Mirus Bio for approximately USD 600 million (around EUR 550 million), following regulatory clearances and the fulfillment of other customary closing conditions.

Global Pharma | 03/08/2024 | By Aishwarya |  839

AbbVie Completes Acquisition of Cerevel Therapeutics

AbbVie has announced the completion of its acquisition of Cerevel Therapeutics.

Global Pharma | 02/08/2024 | By Aishwarya |  825

Indegene Achieves Revenue of INR 6,765 Million in First Quarter FY25

Indegene has announced its financial results, achieving revenue of INR 6,765 million in Q1FY25 with growth of 11.4 percent vs Q1FY24.

Global Pharma | 02/08/2024 | By Aishwarya |  458

Lupin Secures Approval from US FDA for Emtricitabine and Tenofovir Alafenamide Tablets

Lupin has received tentative approval from the United States Food and Drug Administration (US FDA) under the US President’s Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application for Emtricitabine and Tenofovir Alafenamide Tablets, 200 mg/25 mg.

Global Pharma | 01/08/2024 | By Aishwarya |  888

Rubicon Research Announces Filing of DRHP with SEBI

Rubicon Research Ltd. has filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI).

Global Pharma | 01/08/2024 | By Aishwarya |  1999

Waters Introduces New TA Instruments Rapid Screening-DSC for Antibody Drugs

Waters Corporation has launched the TA Instruments Rapid Screening-Differential Scanning Calorimeter (TA Instruments RS-DSC), designed for biopharmaceutical developers.

Global Pharma | 31/07/2024 | By Aishwarya |  793

SSI Strategy to Leverage Metalmind AI Solutions to Enhance its Service Offerings

SSI Strategy has collaborated with MPS Metalmind AB, an innovator in AI services.

Global Pharma | 31/07/2024 | By Aishwarya |  525

Noze Secures New Funding for Disease Detection Technology

Noze has received a USD 5 million equity investment from the Bill and Melinda Gates Foundation.

Global Pharma | 31/07/2024 | By Aishwarya |  785